Dopa-responsive hypersomnia and mixed movement disorder due to sepiapterin reductase deficiency.

Article Details

Citation

Friedman J, Hyland K, Blau N, MacCollin M

Dopa-responsive hypersomnia and mixed movement disorder due to sepiapterin reductase deficiency.

Neurology. 2006 Dec 12;67(11):2032-5.

PubMed ID
17159114 [ View in PubMed
]
Abstract

Sepiapterin reductase deficiency (SRD) is a rare, treatable disorder of monoamine metabolism with cognitive delay and l-dopa responsive movement disorder. We describe a patient with SRD and distinctive phenotypic feature of marked hypersomnolence. Our patient showed improvement with therapies directed at both serotonergic and dopaminergic deficiencies. This case illustrates symptoms that characterize the SRD phenotype and demonstrates the importance of systematic treatment trials addressing the various biochemical abnormalities present.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Sepiapterin reductaseP35270Details